• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清III型前胶原是接受骨髓移植的儿童肝静脉闭塞病的早期敏感标志物。

Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.

作者信息

Heikinheimo M, Halila R, Fasth A

机构信息

Children's Hospital, University of Helsinki, Finland.

出版信息

Blood. 1994 May 15;83(10):3036-40.

PMID:8180401
Abstract

Veno-occlusive disease of the liver (VOD) is a life-threatening complication occurring in patients undergoing bone marrow transplantation (BMT). Although clinical signs and laboratory parameters such as elevation of serum bilirubin often suggest this condition, it would be useful to identify early biochemical markers for VOD. Fibrous alterations in the hepatic venules and small lobular veins occur during development of VOD; these changes are accompanied by the deposition of types I and III collagen in the liver tissue. Since the N-terminal propeptide of type III procollagen (PIIINP) is a sensitive marker of liver and lung fibrosis, we undertook a study to evaluate the usefulness of measurements of serum PIIINP in children with VOD. Seven of the 28 children who underwent BMT, both allogenic and autologous, developed VOD. All seven had an increase of more than 100 ng/mL in the serum PIIINP level, whereas only one of the remaining 21 children not affected by VOD had an increment of PIIINP more than 100 ng/mL (P = .0001). The levels of serum PIIINP were higher in the VOD group during the follow-up period of up to 91 days after BMT. The elevation of PIIINP also occurred at a stage of the disease usually preceding any other laboratory or clinical signs of VOD. Serum concentration of PIIINP thus seems to be of value as an early marker for VOD in children undergoing BMT.

摘要

肝静脉闭塞病(VOD)是接受骨髓移植(BMT)患者中出现的一种危及生命的并发症。尽管临床体征和实验室参数如血清胆红素升高常常提示这种情况,但确定VOD的早期生化标志物将很有帮助。在VOD发生过程中,肝小静脉和小叶内小静脉会出现纤维性改变;这些变化伴随着I型和III型胶原在肝组织中的沉积。由于III型前胶原N端前肽(PIIINP)是肝和肺纤维化的敏感标志物,我们开展了一项研究来评估检测血清PIIINP对VOD患儿的作用。接受同种异体和自体BMT的28名儿童中,有7名发生了VOD。所有7名患儿血清PIIINP水平升高超过100 ng/mL,而其余21名未受VOD影响的儿童中只有1名PIIINP升高超过100 ng/mL(P = .0001)。在BMT后长达91天的随访期内,VOD组的血清PIIINP水平更高。PIIINP升高也发生在疾病的一个阶段,通常先于VOD的任何其他实验室或临床体征出现。因此,血清PIIINP浓度似乎可作为接受BMT儿童VOD的早期标志物。

相似文献

1
Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.血清III型前胶原是接受骨髓移植的儿童肝静脉闭塞病的早期敏感标志物。
Blood. 1994 May 15;83(10):3036-40.
2
Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen.通过血清III型前胶原氨基端前肽监测骨髓移植后的静脉闭塞性疾病。
Lancet. 1993 Aug 28;342(8870):518-21. doi: 10.1016/0140-6736(93)91646-4.
3
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Bone Marrow Transplant. 1997 Mar;19(5):487-90. doi: 10.1038/sj.bmt.1700689.
4
Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.骨髓移植后肝静脉闭塞病患者止血参数的变化
Bone Marrow Transplant. 1997 May;19(9):915-20. doi: 10.1038/sj.bmt.1700760.
5
Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.异基因骨髓移植后肝静脉闭塞病中可溶性白细胞介素-2受体水平升高。
Transplantation. 1995 Dec 15;60(11):1293-9.
6
Evaluation of procollagen-III peptide as a marker for veno-occlusive disease after bone marrow transplantation.评估Ⅲ型前胶原肽作为骨髓移植后肝静脉闭塞病标志物的作用。
Ann Hematol. 1996 Jul;73(1):25-8. doi: 10.1007/s002770050194.
7
N-terminal peptide of type III procollagen: a marker for the development of hepatic veno-occlusive disease after BMT and a basis for determining the timing of prophylactic heparin.III型前胶原N端肽:异基因造血干细胞移植后肝静脉闭塞病发生的标志物及预防性肝素使用时机的判定依据
Bone Marrow Transplant. 1993 Jun;11(6):471-2.
8
Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.肝素预防接受骨髓移植儿童肝静脉闭塞病的II期试验。
Bone Marrow Transplant. 1996 Jul;18(1):185-91.
9
Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation.纤溶酶原激活物抑制剂-1可确诊骨髓移植后高胆红素血症患者的肝静脉闭塞病。
Blood. 1997 Mar 15;89(6):2184-8.
10
Serum tumor marker CA 125 is an early and sensitive indicator of veno-occlusive disease in children undergoing bone marrow transplantation.血清肿瘤标志物CA 125是接受骨髓移植的儿童静脉闭塞性疾病的早期敏感指标。
Clin Cancer Res. 2000 Feb;6(2):531-5.

引用本文的文献

1
Evaluation of thromboelastometry parameters as predictive markers for sinusoidal obstruction syndrome in patients undergoing allogeneic stem cell transplantation for acute leukaemia.评估血栓弹力图参数作为急性白血病异基因干细胞移植患者肝窦阻塞综合征预测标志物的研究。
Oncotarget. 2017 Jun 15;8(35):60001-60014. doi: 10.18632/oncotarget.18499. eCollection 2017 Aug 29.
2
Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes.异基因造血干细胞移植后的窦性阻塞综合征:发病率、危险因素及预后
Bone Marrow Transplant. 2016 Mar;51(3):403-9. doi: 10.1038/bmt.2015.283. Epub 2015 Nov 23.
3
Type I collagen as a marker of bone metabolism in sickle cell hemoglobinopathies.
I型胶原蛋白作为镰状细胞血红蛋白病中骨代谢的标志物。
J Natl Med Assoc. 1998 Jan;90(1):41-5.